what is the dark side of semaglutide A potentially blinding condition a very rare effect GLP-1 receptor agonist (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Harvard and CDC study: Serious

Excessive muscle loss can: A 2023 study published in Obesity found that up to 39% of the weight lost on semaglutide came from lean body massunderscoring the need for protective strategies

While certainly not outweighing the good these medications offer, prescribing physicians need to keep in mind the real and serious ocular adverse events that may occur. I hope this roundup provided you with some information that you didnt previously have

Dual GLP-1/GIP Agonists Dual GLP-1/GIP agonists, such as tirzepatide, represent a significant advancement in incretin-based therapies, offering enhanced efficacy over GLP-1 mono-agonists due to synergistic effects on glucose metabolism, weight loss, and cardiovascular risk factors [14,52]

The way Claviculars celebrity works, everything helps his unkillable viral machine